When CTRP6 was used as a ‘target’ gene in the muTarget analysis, it was revealed that certain mutations in other cancer-related genes, such as TP53, JAK1, IL-17RD, and MAPKAPK2, led to a significant reduction in CTRP6 expression in uterine cancer. The gene discussed is MAPKAPK2; the disease is uterine cancer.